[Progress of therapeutic strategies for glucose metabolic disorders in sepsis]

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Jun;30(6):616-618. doi: 10.3760/cma.j.issn.2095-4352.2018.06.024.
[Article in Chinese]

Abstract

Glucose metabolic disorder is a common issue in sepsis and it leads to an increase in mortality. However, the therapeutic methods of the glucose metabolic disorders in sepsis patients need to be improved. Studying the mechanism of glucose metabolism disorder, and adjusting the existing treatment measures are especially significant in curing the sepsis. This review summarizes recent animal experiments and clinical studies about glucose change after septic complications, focusing on the treatment of three disorders including hyperglycemia, hypoglycemia, and blood glucose variability. They definitely provide new ideas for the control of blood glucose in sepsis patients.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Glucose
  • Humans
  • Hyperglycemia
  • Hypoglycemia
  • Insulin
  • Sepsis*

Substances

  • Blood Glucose
  • Insulin